Childress Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-271
| Closed | -$285K | – | 231 |
|
|
2024
Q3 | $285K | Sell |
271
-1
| -0.4% | -$1.05K | 0.08% | 173 |
|
|
2024
Q2 | $286K | Sell |
272
-7
| -3% | -$7.36K | 0.08% | 158 |
|
|
2024
Q1 | $269K | Sell |
279
-111
| -28% | -$107K | 0.08% | 159 |
|
|
2023
Q4 | $343K | Buy |
390
+28
| +8% | +$24.6K | 0.1% | 123 |
|
|
2023
Q3 | $298K | Buy |
+362
| New | +$298K | 0.1% | 127 |
|
|
2023
Q1 | – | Sell |
-332
| Closed | -$240K | – | 153 |
|
|
2022
Q4 | $240K | Buy |
332
+4
| +1% | +$2.89K | 0.08% | 155 |
|
|
2022
Q3 | $234K | Buy |
+328
| New | +$234K | 0.09% | 145 |
|
|
2021
Q1 | – | Sell |
-63
| Closed | -$29K | – | 769 |
|
|
2020
Q4 | $29K | Buy |
+63
| New | +$29K | 0.02% | 287 |
|